Wolverine Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.25M | Buy |
96,318
+64,734
| +205% | +$3.02M | ﹤0.01% | 1510 |
|
|
2025
Q2 | $1.46M | Buy |
+31,584
| New | +$1.55M | ﹤0.01% | 1952 |
|
|
2025
Q1 | – | Sell |
-69,543
| Closed | -$3.9M | – | 4780 |
|
|
2024
Q4 | $3.9M | Sell |
69,543
-20,508
| -23% | -$1.15M | ﹤0.01% | 1387 |
|
|
2024
Q3 | $4.58M | Buy |
90,051
+33,589
| +59% | +$1.58M | ﹤0.01% | 1103 |
|
|
2024
Q2 | $2.34M | Sell |
56,462
-40,888
| -42% | -$1.83M | ﹤0.01% | 1491 |
|
|
2024
Q1 | $5.28M | Buy |
97,350
+71,188
| +272% | +$3.63M | 0.01% | 984 |
|
|
2023
Q4 | $1.34M | Sell |
26,162
-66,410
| -72% | -$3.49M | ﹤0.01% | 2013 |
|
|
2023
Q3 | $5.37M | Buy |
92,572
+22,826
| +33% | +$1.4M | 0.01% | 953 |
|
|
2023
Q2 | $4.46M | Buy |
+69,746
| New | +$4.68M | 0.01% | 973 |
|
|
2022
Q1 | – | Sell |
-65,733
| Closed | -$4.41M | – | 5420 |
|
|
2021
Q4 | $4.11M | Buy |
65,733
+25,622
| +64% | +$1.5M | ﹤0.01% | 1278 |
|
|
2021
Q3 | $2.43M | Buy |
+40,111
| New | +$2.64M | ﹤0.01% | 1944 |
|
|
2021
Q2 | – | Sell |
-81,834
| Closed | -$5.34M | – | 6023 |
|
|
2021
Q1 | $5.18M | Sell |
81,834
-63,040
| -44% | -$3.92M | 0.01% | 1082 |
|
|
2020
Q4 | $8.97M | Buy |
144,874
+131,275
| +965% | +$8.07M | 0.01% | 742 |
|
|
2020
Q3 | $815K | Sell |
13,599
-19,291
| -59% | -$1.16M | ﹤0.01% | 2278 |
|
|
2020
Q2 | $1.9M | Sell |
32,890
-67,253
| -67% | -$4.02M | 0.01% | 1454 |
|
|
2020
Q1 | $5.45M | Sell |
100,143
-69,373
| -41% | -$4.24M | 0.02% | 724 |
|
|
2019
Q4 | $10.8M | Sell |
169,516
-24,269
| -13% | -$1.39M | 0.03% | 645 |
|
|
2019
Q3 | $9.73M | Sell |
193,785
-33,989
| -15% | -$1.6M | 0.03% | 535 |
|
|
2019
Q2 | $10.3M | Sell |
227,774
-5,154
| -2% | -$240K | 0.03% | 520 |
|
|
2019
Q1 | $11.1M | Buy |
232,928
+145,158
| +165% | +$7.23M | 0.03% | 454 |
|
|
2018
Q4 | $4.47M | Buy |
87,770
+71,230
| +431% | +$3.83M | 0.01% | 885 |
|
|
2018
Q3 | $1.03M | Sell |
16,540
-59,827
| -78% | -$3.55M | ﹤0.01% | 2331 |
|
|
2018
Q2 | $4.83M | Hold |
76,367
| – | – | 0.01% | 900 |
|
|
2018
Q1 | $4.83M | Sell |
76,367
-49,512
| -39% | -$3.19M | 0.01% | 900 |
|
|
2017
Q4 | $7.71M | Buy |
125,879
+110,641
| +726% | +$6.92M | 0.03% | 628 |
|
|
2017
Q3 | $971K | Sell |
15,238
-20,233
| -57% | -$1.18M | ﹤0.01% | 1938 |
|
|
2017
Q2 | $1.98M | Sell |
35,471
-53,459
| -60% | -$2.91M | 0.01% | 1242 |
|
|
2017
Q1 | $4.92M | Sell |
88,930
-19,006
| -18% | -$1.04M | 0.03% | 655 |
|
|
2016
Q4 | $6.31M | Buy |
107,936
+3,476
| +3% | +$190K | 0.03% | 609 |
|
|
2016
Q3 | $5.63M | Buy |
104,460
+91,096
| +682% | +$5.85M | 0.03% | 689 |
|
|
2016
Q2 | $976K | Buy |
+13,364
| New | +$944K | 0.01% | 1614 |
|
Other funds holding BMY
Wolverine Trading's BMY Position: Q3 2025 in Review
Wolverine Trading increased its Bristol-Myers Squibb (BMY) stake by 205% in Q3 2025, buying an estimated $3.02M and bringing the position to 96,318 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.
Wolverine Trading first reported a position in BMY in Q2 2016 and has held it in 31 quarters since. The position peaked at $11.1M in Q1 2019. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Wolverine Trading held 96,318 shares of Bristol-Myers Squibb worth $4.25M as of Q3 2025.
- Wolverine Trading bought 64,734 Bristol-Myers Squibb shares in Q3 2025, an estimated $3.02M.
- Bristol-Myers Squibb made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1510 holding.
- Wolverine Trading first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 31 quarters since.
- Wolverine Trading's Bristol-Myers Squibb position peaked at $11.1M in Q1 2019.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.